Press release
Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market Driver: A Major Catalyst in the Evolution of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market in 2025
Ribose-Nucleic Acid (RNA)-Based Therapeutics
The growing incidence of cancer is likely to boost the development of the ribose-nucleic acid (RNA)-based therapeutics market. Cancer is a condition where abnormal cell growth occurs and spreads unchecked, potentially leading to death if left untreated. The rise in cancer cases is influenced by factors like an aging population, lifestyle changes, greater exposure to risks, and improved detection techniques. RNA-based therapeutics provide a promising cancer treatment by targeting the genetic and molecular mechanisms involved. For example, in August 2023, the Australian Institute of Health and Welfare reported that around 151,000 individuals were diagnosed with cancer in 2021, and this number is projected to rise to 185,000 by 2030. Thus, the increasing prevalence of cancer is contributing to the growth of the RNA-based therapeutics market.
Get Your Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report
What is the projected compound annual growth rate (CAGR) of the ribose-nucleic acid (rna)-based therapeutics market from 2025 to 2034, and what factors influence it?
The ribose-nucleic acid (RNA)-based therapeutics market has experienced strong growth in recent years. It is expected to grow from $15.79 billion in 2024 to $17.26 billion in 2025 at a CAGR of 9.3%. This growth is attributed to increased investment, the discovery of RNA interference (RNAi), clinical successes in antisense oligonucleotides, and supportive regulatory frameworks.
The RNA-based therapeutics market is expected to see strong growth, reaching $24.26 billion by 2029 at a CAGR of 8.9%. The expansion will be fueled by a rise in market demand, adoption, regulatory support, and AI integration, along with emerging applications for rare diseases. Key trends will include the development of advanced delivery systems, multi-target RNA therapeutics, and innovations in regulatory advancements.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
How are the latest trends influencing the growth of the ribose-nucleic acid (rna)-based therapeutics market?
Companies in the RNA-based therapeutics market are focusing on developing mRNA-based booster vaccines to improve immunization efficacy and address emerging viral variants. For example, in June 2023, Gennova Biopharmaceuticals Ltd., an Indian pharmaceutical company, introduced GEMCOVAC-OM, India's first mRNA booster vaccine targeting the Omicron variant of COVID-19. This vaccine boosts immunity and provides enhanced protection against the rapidly evolving virus by using mRNA technology.
What are the major segments of the ribose-nucleic acid (rna)-based therapeutics market and their role in driving growth?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented -
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18454
Which regions are key players in the growth of the ribose-nucleic acid (rna)-based therapeutics market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the ribose-nucleic acid (rna)-based therapeutics market?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=18454&type=smp
What Is Covered In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report?
•Market Size Forecast: Examine the ribose-nucleic acid (rna)-based therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the ribose-nucleic acid (rna)-based therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the ribose-nucleic acid (rna)-based therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ribose-nucleic acid (rna)-based therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the ribose-nucleic acid (rna)-based therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ribose-nucleic acid (rna)-based therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the ribose-nucleic acid (rna)-based therapeutics market.
•Competitive Landscape: Review strategic developments in the ribose-nucleic acid (rna)-based therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market Driver: A Major Catalyst in the Evolution of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market in 2025 here
News-ID: 3934282 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
